Table 1.
Anti-inflammatory activity (CPE% values) of substituted 5-benzyliden-2-adamantylthiazole [3,2-b] [1,2,4] triazol-6(5H)-one.
Com. | R | CPE, a % |
Pa b | Com | R | CPE a % |
Pa b |
---|---|---|---|---|---|---|---|
1 | H | 40 | 0.407 | 14 | 4-NO2 | 42 | 0.409 |
2 | 3-OH | 36 | 0.551 | 15 | 3-F | 51 | 0.581 |
3 | 4-OH | 37 | 0.554 | 16 | 4-F | 56 | 0.566 |
4 | 2,4-OH | 49 | 0.480 | 17 | 2-Br | 67 | 0.274 |
5 | 2-OH, 3-OMe | 58 | 0.485 | 18 | 3-Br | 61 | 0.360 |
6 | 4-OH-3-OMe | 46 | 0.503 | 19 | 4-Br | 53 | 0.393 |
7 | 4-OH, 3,5-OMe | 36 | 0.567 | 20 | 2-Cl | 47 | 0.585 |
8 | 4-OMe | 62 | 0.539 | 21 | 3-Cl | 45 | 0.636 |
9 | 3,4-OMe | 44 | 0.538 | 22 | 4-Cl | 61 | 0.552 |
10 | 3,4,5-OMe | 49 | 0.503 | 23 | 2,3-Cl | 37 | 0366 |
11 | 4-N(CH3)2 | 55 | 0.407 | 24 | 2,4-Cl | 37 | |
12 | 2-NO2 | 40 | 0.409 | 25 | 2,6-Cl | 32 | 0.585 |
13 | 3-NO2 | 15 | - | indomethacin | 47 |
a-CPE—carrageenan paw edema; b—probability to be active.